Evaluating a new valve system for chronic venous insufficiency
Official title: Feasibility of the InnoVein Valve and Delivery System for Chronic Venous Insufficiency
Run by InnoVein · NCT04253301 · Data updated 2026-11-12
This study is testing a new valve system to see if it can safely help people with chronic venous insufficiency by improving blood flow in their legs.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 5 (estimated) |
| Sponsor | InnoVein Industry-sponsored |
| Locations | 3 sites (Nedlands, Western Australia and 2 other locations) |
| Status | Recruiting |
| Started | January 15, 2020 |
| Main results expected | February 15, 2022 |
| Study ends | January 15, 2027 |
| Registry record updated | September 17, 2021 |
| Trial ID | NCT04253301 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are individuals diagnosed with symptomatic non-obstructive chronic valvular insufficiency of the femoral vein who can provide informed consent.
✕Probably not a fit
Patients with a history of multiple deep vein thromboses or those with inadequate venous inflow or outflow may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This feasibility study aims to assess the safety of the InnoVein Valve and Delivery System in treating chronic venous insufficiency, a condition where ineffective venous valves lead to blood pooling in the legs. The study focuses on patients with symptomatic non-obstructive chronic valvular insufficiency of the femoral vein. Participants will receive the investigational biocompatible valve, which is designed to restore natural blood flow. The study will monitor safety outcomes related to the valve's implantation and functionality.
Why it matters
Potential benefit: If successful, this treatment could significantly alleviate symptoms and improve quality of life for patients suffering from chronic venous insufficiency.
How similar studies have gone: While this approach is novel, similar studies evaluating valve implantation for venous insufficiency have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Key Inclusion Criteria: * Willing and able to provide written Informed Consent * Diagnosis of symptomatic non-obstructive chronic valvular insufficiency of the femoral vein * Willing and medically able to receive intraprocedural and post-procedural anticoagulation medication * Life expectancy \>1yr * Reflux time \>1s in the superficial femoral and/or popliteal vein Key Exclusion Criteria: * Any prior deep vein intervention within 6 months prior to the Index Procedure * History of 2+ DVTs * Inadequate inflow to the femoral vein or inadequate outflow through the femoral vein, iliac vein, or IVC * Current IVC Placement * History of pulmonary embolism within 6 months * Conditions that increase the risk of device thrombosis or patient bleeding * Any planned surgical or interventional procedure within 30 days prior to or after the Index Procedure * Investigator or sponsor believes the subject would not benefit, would not be appropriate, be unable to follow-up, or be at high risk for non-compliance with the protocol
Where it's running
-
Hollywood Private Hospital
Nedlands, Western Australia, Australia Recruiting -
Sir Charles Gairdner Hospital
Nedlands, Western Australia, Australia Recruiting -
Flinders
Adelaide, Australia Recruiting
Study contacts
- Study coordinator: InnoVen Data Management
- Email: IM-CP-2001@innoveinmedical.com
- Phone: 650-302-0847
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Laser crossectomy with 1470 nm versus 1940 nm to prevent varicose vein recurrence
This will test whether doing a flush laser crossectomy with either a 1470 nm or 1940 nm laser lowers the chance of varicose vein recurrence and heat-related clots in adults with great saphenous vein reflux.
-
Photobiomodulation plus compression for venous leg ulcers
This trial tests whether adding photobiomodulation to standard compression therapy helps healing venous leg ulcers.
-
Evaluation of a new portable compression device for lymphedema
This study is testing a new portable compression device to see if it helps people with lymphedema and chronic venous issues feel better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.